AzTrials
AzTrials

Obesity, MorbidNCT07880691

Weight Loss and Comorbidity Outcomes After Revisional Bariatric Surgery

An observational study of Obesity, Morbid and Weight Regain After Bariatric Surgery, run by Kasr El Aini Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Some people who have had weight-loss (bariatric) surgery do not lose enough weight, regain much of the weight they lost, see obesity-related diseases such as diabetes or high blood pressure return, or develop complications of the first operation. Many of them need a second, revisional operation. Read more about this study

Who is it for?
Ages 25 to 65 years
What is being tested?
Revisional bariatric surgery
Type of treatment
Surgery or procedure
How many people
96 participants
Where
No sites listed yet
Study dates
1 Jan 2017to 30 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults aged 25 to 65 years who underwent revisional bariatric surgery in the Department of General Surgery between 2017 and 2025 after one or more previous bariatric operations, identified from the centre's follow-up records.

Who may be able to join

  • Age 25 to 65 years.
  • One or more previous bariatric operations.
  • Revisional bariatric surgery performed at the study centre between 2017 and 2025.
  • Revision performed for at least one of the following:
  • Insufficient weight loss: %EWL below 50% or BMI above 35 kg/m2 at least 18 months after the primary operation.
  • Weight regain: BMI rising to 35 kg/m2 or more after successful weight loss, a gain of more than 10 kg from the lowest weight, or an increase of 5 kg/m2 from the lowest BMI.
  • Recurrence of obesity-related comorbidities.
  • Complications of the primary operation requiring revision.

Who cannot join

  • Uncontrolled psychiatric illness.
  • Substance abuse.
  • Severe hepatic or renal dysfunction.
  • Non-compliance with long-term follow-up.

About this study

Official title: Outcomes of Revisional Bariatric Surgery for Insufficient Weight Loss, Weight Regain, Recurrent Comorbidities or Complications of the Primary Operation: A Retrospective Single-Centre Cohort Study

Some people who have had weight-loss (bariatric) surgery do not lose enough weight, regain much of the weight they lost, see obesity-related diseases such as diabetes or high blood pressure return, or develop complications of the first operation. Many of them need a second, revisional operation.

This study reviews the medical records of adults who had revisional bariatric surgery between 2017 and 2025 at a single surgical centre. It describes which revisional operations were performed after each type of first operation and measures how much weight patients lost 6 months, 12 months and up to 3 years after the revision. It also records whether obesity-related diseases and quality of life improved after the revision, and looks at patient factors linked to better weight loss.

Read the detailed description

Background Revisional bariatric surgery is performed when a primary bariatric operation results in insufficient weight loss or weight regain, when obesity-related comorbidities recur, or when complications of the primary operation require revision. The choice of revisional procedure depends largely on the primary operation, and outcome data across the range of primary and revisional procedures remain limited.

Design and setting Retrospective, single-centre, observational cohort study of patients who underwent revisional bariatric surgery in the Department of General Surgery between 2017 and 2025. Data are extracted from the centre's follow-up records. The study was approved by the scientific committee of the Department of General Surgery and the institutional research ethics committee, and is reported according to the STROBE guideline.

Data collected Age, sex and height; the primary bariatric procedure and its year; reflux (GERD) symptoms before and after the primary operation; complications of the primary operation; weight before the primary operation, the lowest weight reached after it and the weight before revision; the interval from the primary operation to weight rebound; satisfaction with weight loss after the primary operation; the revisional procedure and its date; weights at 6 months, 12 months and 3 years after revision; obesity-related comorbidities and their outcome after revision; and quality of life after revision.

Revisional procedures Roux-en-Y gastric bypass (RYGB), banded RYGB, one-anastomosis gastric bypass (OAGB), single-anastomosis duodeno-ileal bypass (SADI), SADI with sleeve gastrectomy (SADI-S), re-sleeve or conversion to sleeve gastrectomy (LSG), distalisation of a bypass, and reversal of the primary operation.

Definitions BMI = weight (kg) / height (m) squared. Weight regain = weight before revision minus the lowest weight after the primary operation. Total weight loss: %TWL = (weight before revision - follow-up weight) / weight before revision x 100. Excess weight loss: %EWL = (weight before revision - follow-up weight) / (weight before revision - weight at BMI 25 kg/m2) x 100, calculated only for patients with a recorded height. A successful result is defined as %EWL of 50% or more.

Data management Source data are cleaned before analysis (date conversion, standardisation of free text, checking of implausible values). Missing values are not imputed; each analysis is a complete-case analysis and the number of patients analysed is reported for every result.

Statistical analysis SPSS 27 and Python 3 (SciPy). Categorical variables as n (%) with Wilson 95% confidence intervals for the main proportions; continuous variables as mean +/- SD or median (IQR), with normality assessed by the Shapiro-Wilk test. Paired weights are compared with the paired t test and Wilcoxon signed-rank test (Cohen's d for paired samples); weights at the four time points with the Friedman test followed by pairwise Wilcoxon tests with Bonferroni correction. Independent groups are compared with the Mann-Whitney U or Kruskal-Wallis test; paired proportions with the exact McNemar test; unpaired proportions with Fisher's exact test or a permutation chi-square test. Associations are assessed with Spearman correlation, and a multiple linear regression examines factors associated with %TWL at 12 months after conversion procedures (age, sex, weight before revision, years from primary operation to revision, and LSG versus bypass-type revision). Reversal and distalisation operations are excluded from group comparisons and the regression. Tests are two-sided with p < 0.05 considered significant; comparisons between revisional procedures are exploratory. The protocol sample-size calculation (alpha 0.05, power 80%) targeted 164 patients.

Being tested
Revisional bariatric surgery
Keywords
Revisional bariatric surgery, Conversional bariatric surgery, Weight regain, Roux-en-Y gastric bypass, One-anastomosis gastric bypass, SADI-S, Sleeve gastrectomy, Vertical banded gastroplasty, Adjustable gastric band, Total weight loss
Medical subject headings
Obesity, Morbid, Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Revisional bariatric surgeryProcedure or surgery

    Revisional or conversional bariatric operation after a previous bariatric procedure, as chosen by the treating team: Roux-en-Y gastric bypass (RYGB), banded RYGB, one-anastomosis gastric bypass (OAGB), single-anastomosis duodeno-ileal bypass (SADI), SADI with sleeve gastrectomy (SADI-S), re-sleeve or conversion to sleeve gastrectomy, distalisation of a bypass, or reversal of the primary operation.

Study groups in NCT07880691
Study groupRoleWhat they receive
Revisional bariatric surgery cohortAdults aged 25 to 65 years who underwent revisional bariatric surgery between 2017 and 2025 after one or more previous bariatric operations, for insufficient weight loss, weight regain, recurrence of comorbidities or complications of the primary operation.
Receives: Procedure: Revisional bariatric surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Total Weight Loss (%TWL) After Revisional Bariatric Surgery

    Weight loss after revision expressed as the percentage of total weight loss (%TWL), calculated as: %TWL = [(body weight before revision - body weight at follow-up) / body weight before revision] x 100. Body weight is measured in kilograms (kg) on a clinic weighing scale before revision and at each follow-up visit, and recorded in the patient's follow-up file. Unit of measure: percentage (%) of pre-revision body weight.

    Measured: 6 months, 12 months and 3 years after revisional surgery

  2. Percentage of Excess Weight Loss (%EWL) After Revisional Bariatric Surgery

    Weight loss after revision expressed as the percentage of excess weight loss (%EWL), calculated as: %EWL = [(body weight before revision - body weight at follow-up) / (body weight before revision - ideal body weight)] x 100, where ideal body weight is the weight corresponding to a body mass index (BMI) of 25 kg/m2 for the patient's height. Body weight is measured in kilograms (kg) on a clinic weighing scale and height in metres (m); both are recorded in the patient's follow-up file. Unit of measure: percentage (%) of excess body weight.

    Measured: 6 months, 12 months and 3 years after revisional surgery

Secondary outcomes (3)
  1. Percentage of Patients With Improvement of Obesity-Related Comorbidities After Revisional Surgery

    Among patients with at least one obesity-related comorbidity before revision (such as hypertension, type 2 diabetes mellitus, dyslipidaemia or asthma), the percentage whose comorbidity improved after revision. Each comorbidity is assessed clinically by the treating surgical team at follow-up and recorded in the patient's follow-up file as "improved" or "not improved". Unit of measure: percentage (%) of patients.

    Measured: Up to 3 years after revisional surgery

  2. Percentage of Patients Reporting Improved Quality of Life After Revisional Surgery

    Patient-reported overall quality of life after revision compared with before revision. At follow-up, patients are asked whether their overall quality of life has improved after the revisional operation, and the answer is recorded in the patient's follow-up file as "improved" or "not improved". No validated quality-of-life questionnaire is used. Unit of measure: percentage (%) of patients.

    Measured: Up to 3 years after revisional surgery

  3. Number of Patients With Complications of Revisional Surgery

    Number of patients with any intraoperative or postoperative complication related to the revisional operation, as documented by the treating surgical team in the patient's medical and follow-up records. Unit of measure: number of patients.

    Measured: From the day of revisional surgery up to 3 years after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2026
  2. Study start1 Jan 2017
  3. Primary completion1 Apr 2025
  4. Study completion30 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
96 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07880691
Sponsor's protocol ID
RevBariatric-Cohort-2017-2025
Status last verified
Oct 2026
First submitted
8 Oct 2026
Last updated
19 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared; aggregate results are reported in the publication.

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity, Morbid and Weight Regain After Bariatric Surgery, run by Kasr El Aini Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Total Weight Loss (%TWL) After Revisional Bariatric Surgery (time frame: 6 months, 12 months and 3 years after revisional surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in